The Natural Flavonoid Pinocembrin: Molecular Targets and Potential Therapeutic Applications

Molecular Neurobiology

Volumn 53, Issue 3, 2016, Pages 1794-1801

  Lan, Xi ^a   Wang, Wenzhu ^a   Li, Qiang ^a   Wang, Jian ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Neuroinflammation; Neuroprotection; Pinocembrin; Stroke

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; CASPASE 3; EPOXIDE HYDROLASE; EPOXYICOSATRIENOIC ACID; PINOCEMBRINE; FLAVANONE DERIVATIVE; FLAVONOID; NEUROPROTECTIVE AGENT;

ANTIFUNGAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ATHEROSCLEROSIS; BRAIN ISCHEMIA; DEGENERATIVE DISEASE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME ACTIVITY; HUMAN; IN VITRO STUDY; INFECTION; INFLAMMATORY DISEASE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOLECULARLY TARGETED THERAPY; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; REVIEW; SEPTIC SHOCK; ANIMAL; BIOLOGICAL MODEL; BIOSYNTHESIS;

ANIMALS; FLAVANONES; FLAVONOIDS; HUMANS; MODELS, BIOLOGICAL; NEUROPROTECTIVE AGENTS;

EID: 84959383152     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-015-9125-2     Document Type: Review

References (73)

1. Massaro CF, Katouli M, Grkovic T, Vu H, Quinn RJ, Heard TA, Carvalho C, Manley-Harris M et al (2014) Anti-staphylococcal activity of C-methyl flavanones from propolis of Australian stingless bees (Tetragonula carbonaria) and fruit resins of Corymbia torelliana (Myrtaceae). Fitoterapia. doi:10.1016/j.fitote.2014.03.024
2. Danert FC, Zampini C, Ordonez R, Maldonado L, Bedascarrasbure E, Isla MI (2014) Nutritional and functional properties of aqueous and hydroalcoholic extracts from Argentinean propolis. Nat Prod Commun 9(2):167–170
3. Bertelli D, Papotti G, Bortolotti L, Marcazzan GL, Plessi M (2012) (1)H-NMR simultaneous identification of health-relevant compounds in propolis extracts. Phytochem Anal 23(3):260–266. doi:10.1002/pca.1352
4. Tuchinda P, Reutrakul V, Claeson P, Pongprayoon U, Sematong T, Santisuk T, Taylor WC (2002) Anti-inflammatory cyclohexenyl chalcone derivatives in Boesenbergia pandurata. Phytochemistry 59(2):169–173
5. Gao M, Zhu SY, Tan CB, Xu B, Zhang WC, Du GH (2010) Pinocembrin protects the neurovascular unit by reducing inflammation and extracellular proteolysis in MCAO rats. J Asian Nat Prod Res 12(5):407–418. doi:10.1080/10286020.2010.485129
6. Stashenko EE, Martinez JR, Ruiz CA, Arias G, Duran C, Salgar W, Cala M (2010) Lippia origanoides chemotype differentiation based on essential oil GC-MS and principal component analysis. J Sep Sci 33(1):93–103. doi:10.1002/jssc.200900452
7. Diaz Napal GN, Palacios SM (2013) Phytotoxicity of secondary metabolites isolated from Flourensia oolepis S.F.Blake. Chem Biodivers 10(7):1295–1304. doi:10.1002/cbdv.201200204
8. Leonard E, Lim KH, Saw PN, Koffas MA (2007) Engineering central metabolic pathways for high-level flavonoid production in Escherichia coli. Appl Environ Microbiol 73(12):3877–3886. doi:10.1128/AEM. 00200-07
9. Miyahisa I, Funa N, Ohnishi Y, Martens S, Moriguchi T, Horinouchi S (2006) Combinatorial biosynthesis of flavones and flavonols in Escherichia coli. Appl Microbiol Biotechnol 71(1):53–58. doi:10.1007/s00253-005-0116-5
10. Park SR, Yoon JA, Paik JH, Park JW, Jung WS, Ban YH, Kim EJ, Yoo YJ et al (2009) Engineering of plant-specific phenylpropanoids biosynthesis in Streptomyces venezuelae. J Biotechnol 141(3–4):181–188. doi:10.1016/j.jbiotec.2009.03.013
11. Bremner PD, Meyer JJ (1998) Pinocembrin chalcone: an antibacterial compound from Helichrysum trilineatum. Planta Med 64(8):777. doi:10.1055/s-2006-957585
12. Chang LS, Li CB, Qin N, Jin MN, Duan HQ (2012) Synthesis and antidiabetic activity of 5,7-dihydroxyflavonoids and analogs. Chem Biodivers 9(1):162–169. doi:10.1002/cbdv.201100049
13. Miyahisa I, Kaneko M, Funa N, Kawasaki H, Kojima H, Ohnishi Y, Horinouchi S (2005) Efficient production of (2S)-flavanones by Escherichia coli containing an artificial biosynthetic gene cluster. Appl Microbiol Biotechnol 68(4):498–504. doi:10.1007/s00253-005-1916-3
14. Wu J, Du G, Zhou J, Chen J (2013) Metabolic engineering of Escherichia coli for (2S)-pinocembrin production from glucose by a modular metabolic strategy. Metab Eng 16:48–55. doi:10.1016/j.ymben.2012.11.009
15. Yuan Y, Yang QY, Tong YF, Chen F, Qi Y, Duan YB, Wu S (2008) Synthesis and enantiomeric resolution of (+/-)-pinocembrin. J Asian Nat Prod Res 10(9–10):999–1002. doi:10.1080/10286020802240418
16. Rasul A, Millimouno FM, Ali Eltayb W, Ali M, Li J, Li X (2013) Pinocembrin: a novel natural compound with versatile pharmacological and biological activities. Biomed Res Int 2013:379850. doi:10.1155/2013/379850
17. Sayre CL, Takemoto JK, Martinez SE, Davies NM (2013) Chiral analytical method development and application to pre-clinical pharmacokinetics of pinocembrin. Biomed Chromatogr 27(6):681–684. doi:10.1002/bmc.2853
18. Metzner J, Bekemeier H, Schneidewind EM, Wenzel U (1979) Pharmacokinetic studies of the propolis constituent pinocembrin in the rat (author’s transl). Pharmazie 34(3):185–187
19. Park YK, Koo MH, Abreu JA, Ikegaki M, Cury JA, Rosalen PL (1998) Antimicrobial activity of propolis on oral microorganisms. Curr Microbiol 36(1):24–28
20. Yang ZH, Sun X, Qi Y, Mei C, Sun XB, Du GH (2012) Uptake characteristics of pinocembrin and its effect on p-glycoprotein at the blood-brain barrier in in vitro cell experiments. J Asian Nat Prod Res 14(1):14–21. doi:10.1080/10286020.2011.620393
21. Yan B, Cao G, Sun T, Zhao X, Hu X, Yan J, Peng Y, Shi A et al (2014) Determination of pinocembrin in human plasma by solid-phase extraction and LC/MS/MS: application to pharmacokinetic studies. Biomed Chromatogr. doi:10.1002/bmc.3186
22. National Institutes of Health (2014) Phase II study of pinocembrin injection to treat ischemic stroke. http://www.clinicaltrials.gov/ct2/show/NCT02059785?term=pinocembrin&rank=1.
23. Yang Z, Liu R, Li X, Tian S, Liu Q, Du G (2009) Development and validation of a high-performance liquid chromatographic method for determination of pinocembrin in rat plasma: application to pharmacokinetic study. J Pharm Biomed Anal 49(5):1277–1281. doi:10.1016/j.jpba.2009.02.030
24. Liu YL, Ho DK, Cassady JM, Cook VM, Baird WM (1992) Isolation of potential cancer chemopreventive agents from Eriodictyon californicum. J Nat Prod 55(3):357–363
25. Weisshaar B, Jenkins GI (1998) Phenylpropanoid biosynthesis and its regulation. Curr Opin Plant Biol 1(3):251–257
26. Kaneko M, Hwang EI, Ohnishi Y, Horinouchi S (2003) Heterologous production of flavanones in Escherichia coli: potential for combinatorial biosynthesis of flavonoids in bacteria. J Ind Microbiol Biotechnol 30(8):456–461. doi:10.1007/s10295-003-0061-1
27. Yan Y, Kohli A, Koffas MA (2005) Biosynthesis of natural flavanones in Saccharomyces cerevisiae. Appl Environ Microbiol 71(9):5610–5613. doi:10.1128/AEM. 71.9.5610-5613.2005
28. Kim BG, Lee H, Ahn JH (2014) Biosynthesis of pinocembrin from glucose using engineered Escherichia coli. J Microbiol Biotechnol 24(11):1536–1541
29. Gao M, Liu R, Zhu SY, Du GH (2008) Acute neurovascular unit protective action of pinocembrin against permanent cerebral ischemia in rats. J Asian Nat Prod Res 10(5–6):551–558. doi:10.1080/10286020801966955
30. Liu R, Gao M, Yang ZH, Du GH (2008) Pinocembrin protects rat brain against oxidation and apoptosis induced by ischemia-reperfusion both in vivo and in vitro. Brain Res 1216:104–115. doi:10.1016/j.brainres.2008.03.049
31. Wu CX, Liu R, Gao M, Zhao G, Wu S, Wu CF, Du GH (2013) Pinocembrin protects brain against ischemia/reperfusion injury by attenuating endoplasmic reticulum stress induced apoptosis. Neurosci Lett 546:57–62. doi:10.1016/j.neulet.2013.04.060
32. Meng F, Liu R, Gao M, Wang Y, Yu X, Xuan Z, Sun J, Yang F et al (2011) Pinocembrin attenuates blood-brain barrier injury induced by global cerebral ischemia-reperfusion in rats. Brain Res 1391:93–101. doi:10.1016/j.brainres.2011.03.010
33. Shi LL, Chen BN, Gao M, Zhang HA, Li YJ, Wang L, Du GH (2011) The characteristics of therapeutic effect of pinocembrin in transient global brain ischemia/reperfusion rats. Life Sci 88(11–12):521–528. doi:10.1016/j.lfs.2011.01.011
34. Gao M, Zhang WC, Liu QS, Hu JJ, Liu GT, Du GH (2008) Pinocembrin prevents glutamate-induced apoptosis in SH-SY5Y neuronal cells via decrease of bax/bcl-2 ratio. Eur J Pharmacol 591(1–3):73–79. doi:10.1016/j.ejphar.2008.06.071
35. Liu R, Li JZ, Song JK, Zhou D, Huang C, Bai XY, Xie T, Zhang X et al (2014) Pinocembrin improves cognition and protects the neurovascular unit in Alzheimer related deficits. Neurobiol Aging 35(6):1275–1285. doi:10.1016/j.neurobiolaging.2013.12.031
36. Liu R, Wu CX, Zhou D, Yang F, Tian S, Zhang L, Zhang TT, Du GH (2012) Pinocembrin protects against beta-amyloid-induced toxicity in neurons through inhibiting receptor for advanced glycation end products (RAGE)-independent signaling pathways and regulating mitochondrion-mediated apoptosis. BMC Med 10:105. doi:10.1186/1741-7015-10-105
37. Yang N, Qin S, Wang M, Chen B, Yuan N, Fang Y, Yao S, Jiao P et al (2013) Pinocembrin, a major flavonoid in propolis, improves the biological functions of EPCs derived from rat bone marrow through the PI3K-eNOS-NO signaling pathway. Cytotechnology 65(4):541–551. doi:10.1007/s10616-012-9502-x
38. Li L, Yang HG, Yuan TY, Zhao Y, Du GH (2013) Rho kinase inhibition activity of pinocembrin in rat aortic rings contracted by angiotensin II. Chin J Nat Med 11(3):258–263. doi:10.1016/S1875-5364(13)60025-4
39. Soromou LW, Chu X, Jiang L, Wei M, Huo M, Chen N, Guan S, Yang X et al (2012) In vitro and in vivo protection provided by pinocembrin against lipopolysaccharide-induced inflammatory responses. Int Immunopharmacol 14(1):66–74. doi:10.1016/j.intimp.2012.06.009
40. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, de Ferranti S, Despres JP, Fullerton HJ, Howard VJ, Huffman MD, Judd SE, Kissela BM, Lackland DT, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Matchar DB, McGuire DK, Mohler ER, 3rd, Moy CS, Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Willey JZ, Woo D, Yeh RW, Turner MB, American Heart Association Statistics C, Stroke Statistics S (2015) Executive summary: heart disease and stroke statistics—2015 update: a report from the American Heart Association. Circulation 131(4):434–441. doi:10.1161/CIR.0000000000000157
41. Izuta H, Shimazawa M, Tazawa S, Araki Y, Mishima S, Hara H (2008) Protective effects of Chinese propolis and its component, chrysin, against neuronal cell death via inhibition of mitochondrial apoptosis pathway in SH-SY5Y cells. J Agric Food Chem 56(19):8944–8953. doi:10.1021/jf8014206
42. Wang SB, Pang XB, Gao M, Fang LH, Du GH (2013) Pinocembrin protects rats against cerebral ischemic damage through soluble epoxide hydrolase and epoxyeicosatrienoic acids. Chin J Nat Med 11(3):207–213. doi:10.1016/S1875-5364(13)60018-7
43. Iliff JJ, Alkayed NJ (2009) Soluble epoxide hydrolase inhibition: targeting multiple mechanisms of ischemic brain injury with a single agent. Future Neurol 4(2):179–199
44. Node K, Huo Y, Ruan X, Yang B, Spiecker M, Ley K, Zeldin DC, Liao JK (1999) Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids. Science 285(5431):1276–1279
45. Capdevila JH, Falck JR (2001) The CYP P450 arachidonic acid monooxygenases: from cell signaling to blood pressure regulation. Biochem Biophys Res Commun 285(3):571–576. doi:10.1006/bbrc.2001.5167
46. Imig JD, Simpkins AN, Renic M, Harder DR (2011) Cytochrome P450 eicosanoids and cerebral vascular function. Expert Rev Mol Med 13:e7. doi:10.1017/S1462399411001773
47. Bellien J, Joannides R (2013) Epoxyeicosatrienoic acid pathway in human health and diseases. J Cardiovasc Pharmacol 61(3):188–196. doi:10.1097/FJC.0b013e318273b007
48. Sura P, Sura R, Enayetallah AE, Grant DF (2008) Distribution and expression of soluble epoxide hydrolase in human brain. J Histochem Cytochem 56(6):551–559. doi:10.1369/jhc.2008.950659
49. Jouihan SA, Zuloaga KL, Zhang W, Shangraw RE, Krasnow SM, Marks DL, Alkayed NJ (2013) Role of soluble epoxide hydrolase in exacerbation of stroke by streptozotocin-induced type 1 diabetes mellitus. J Cereb Blood Flow Metab 33(10):1650–1656. doi:10.1038/jcbfm.2013.130
50. Zhang W, Koerner IP, Noppens R, Grafe M, Tsai HJ, Morisseau C, Luria A, Hammock BD et al (2007) Soluble epoxide hydrolase: a novel therapeutic target in stroke. J Cereb Blood Flow Metab 27(12):1931–1940. doi:10.1038/sj.jcbfm.9600494
51. Zhang W, Otsuka T, Sugo N, Ardeshiri A, Alhadid YK, Iliff JJ, DeBarber AE, Koop DR et al (2008) Soluble epoxide hydrolase gene deletion is protective against experimental cerebral ischemia. Stroke 39(7):2073–2078. doi:10.1161/STROKEAHA.107.508325
52. Shaik JS, Ahmad M, Li W, Rose ME, Foley LM, Hitchens TK, Graham SH, Hwang SH et al (2013) Soluble epoxide hydrolase inhibitor trans-4-[4-(3-adamantan-1-yl-ureido)-cyclohexyloxy]-benzoic acid is neuroprotective in rat model of ischemic stroke. Am J Physiol Heart Circ Physiol 305(11):H1605–H1613. doi:10.1152/ajpheart.00471.2013
53. Brenneis C, Sisignano M, Coste O, Altenrath K, Fischer MJ, Angioni C, Fleming I, Brandes RP et al (2011) Soluble epoxide hydrolase limits mechanical hyperalgesia during inflammation. Mol Pain 7:78. doi:10.1186/1744-8069-7-78
54. Boudreau DM, Guzauskas GF, Chen E, Lalla D, Tayama D, Fagan SC, Veenstra DL (2014) Cost-effectiveness of recombinant tissue-type plasminogen activator within 3 hours of acute ischemic stroke: current evidence. Stroke 45(10):3032–3039. doi:10.1161/STROKEAHA.114.005852
55. Wang Y, Gao J, Miao Y, Cui Q, Zhao W, Zhang J, Wang H (2014) Pinocembrin protects SH-SY5Y cells against MPP(+)-induced neurotoxicity through the mitochondrial apoptotic pathway. J Mol Neurosci 53(4):537–545. doi:10.1007/s12031-013-0219-x
56. Jin X, Liu Q, Jia L, Li M, Wang X (2014) Pinocembrin attenuates 6-OHDA-induced neuronal cell death through Nrf2/ARE pathway in SH-SY5Y cells. Cell Mol Neurobiol. doi:10.1007/s10571-014-0128-8
57. Sang H, Yuan N, Yao S, Li F, Wang J, Fang Y, Qin S (2012) Inhibitory effect of the combination therapy of simvastatin and pinocembrin on atherosclerosis in ApoE-deficient mice. Lipids Health Dis 11:166. doi:10.1186/1476-511X-11-166
58. Soromou LW, Jiang L, Wei M, Chen N, Huo M, Chu X, Zhong W, Wu Q et al (2014) Protection of mice against lipopolysaccharide-induced endotoxic shock by pinocembrin is correlated with regulation of cytokine secretion. J Immunotoxicol 11(1):56–61. doi:10.3109/1547691X.2013.792886
59. Metzner J, Schneidewind EM, Friedrich E (1977) Effect of propolis and pinocembrin on fungi. Pharmazie 32(11):730
60. Sala A, Recio MC, Schinella GR, Manez S, Giner RM, Cerda-Nicolas M, Rosi JL (2003) Assessment of the anti-inflammatory activity and free radical scavenger activity of tiliroside. Eur J Pharmacol 461(1):53–61
61. Katerere DR, Gray AI, Nash RJ, Waigh RD (2012) Phytochemical and antimicrobial investigations of stilbenoids and flavonoids isolated from three species of Combretaceae. Fitoterapia 83(5):932–940. doi:10.1016/j.fitote.2012.04.011
62. Metzner J, Schneidewind EM (1978) Effect of pinocembrin on the course of experimental candida infections in mice. Mykosen 21(8):257–262
63. Metzner J, Bekemeier H, Paintz M, Schneidewind E (1979) On the antimicrobial activity of propolis and propolis constituents (author's transl). Pharmazie 34(2):97–102
64. Lopez A, Ming DS, Towers GH (2002) Antifungal activity of benzoic acid derivatives from Piper lanceaefolium. J Nat Prod 65(1):62–64
65. Uzel A, Sorkun K, Oncag O, Cogulu D, Gencay O, Salih B (2005) Chemical compositions and antimicrobial activities of four different Anatolian propolis samples. Microbiol Res 160(2):189–195
66. Soromou LW, Zhang Y, Cui Y, Wei M, Chen N, Yang X, Huo M, Balde A et al (2013) Subinhibitory concentrations of pinocembrin exert anti-Staphylococcus aureus activity by reducing alpha-toxin expression. J Appl Microbiol 115(1):41–49. doi:10.1111/jam.12221
67. Peralta MA, Calise M, Fornari MC, Ortega MG, Diez RA, Cabrera JL, Perez C (2012) A prenylated flavanone from Dalea elegans inhibits rhodamine 6 G efflux and reverses fluconazole-resistance in Candida albicans. Planta Med 78(10):981–987. doi:10.1055/s-0031-1298627
68. Estevinho L, Pereira AP, Moreira L, Dias LG, Pereira E (2008) Antioxidant and antimicrobial effects of phenolic compounds extracts of Northeast Portugal honey. Food Chem Toxicol 46(12):3774–3779. doi:10.1016/j.fct.2008.09.062
69. Drewes SE, van Vuuren SF (2008) Antimicrobial acylphloroglucinols and dibenzyloxy flavonoids from flowers of Helichrysum gymnocomum. Phytochemistry 69(8):1745–1749. doi:10.1016/j.phytochem.2008.02.022
70. Hegazi AG, Abd El Hady FK, Abd Allah FA (2000) Chemical composition and antimicrobial activity of European propolis. Z Naturforsch C 55(1–2):70–75
71. Barrientos L, Herrera CL, Montenegro G, Ortega X, Veloz J, Alvear M, Cuevas A, Saavedra N et al (2013) Chemical and botanical characterization of Chilean propolis and biological activity on cariogenic bacteria Streptococcus mutans and Streptococcus sobrinus. Braz J Microbiol 44(2):577–585. doi:10.1590/S1517-83822013000200038
72. Ruddock PS, Charland M, Ramirez S, Lopez A, Neil Towers GH, Arnason JT, Liao M, Dillon JA (2011) Antimicrobial activity of flavonoids from Piper lanceaefolium and other Colombian medicinal plants against antibiotic susceptible and resistant strains of Neisseria gonorrhoeae. Sex Transm Dis 38(2):82–88. doi:10.1097/OLQ.0b013e3181f0bdbd
73. Wang J (2010) Preclinical and clinical research on inflammation after intracerebral hemorrhage. Prog Neurobiol 92(4):463–477